The renin–angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications

Author:
Open Access
Publisher website
Google Scholar
Abstract
The renin–angiotensin system (RAS) has long been appreciated as a major regulator of blood pressure, but has more recently been recognized as a mechanism for modulating inflammation as well. While there has been concern in COVID-19 patients over the use of drugs that target this system, the RAS has not been explored fully as a druggable target. The abbreviated description of the RAS suggests that its dysregulation may be at the center of COVID-19.
Funding Information
  • National Institutes of Health (NIH P01AI073693, NIH R03-AR065157)

This publication has 36 references indexed in Scilit: